Primary prevention of dementia

Alzheimer's and Dementia

Volumn 3, Issue 4, 2007, Pages 348-354

  Patterson, Christopher ^a   Feightner, John ^b   Garcia, Angeles ^c   MacKnight, Chris ^d  

^a Health Science Center   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c QUEEN S UNIVERSITY   (Canada)

^d DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Alzheimer's disease; Dementia; Primary prevention; Vascular dementia

Indexed keywords

ALPHA TOCOPHEROL; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ASCORBIC ACID; BENZODIAZEPINE DERIVATIVE; CELECOXIB; CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE; ENALAPRIL; ESTROGEN; GESTAGEN; HOMOCYSTEINE; HYDROCHLOROTHIAZIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INDAPAMIDE; NAPROXEN; NITRENDIPINE; NONSTEROID ANTIINFLAMMATORY AGENT; PERINDOPRIL; PESTICIDE; PLACEBO; PRAVASTATIN; TOXIN; VACCINE;

ALCOHOL CONSUMPTION; ALZHEIMER DISEASE; ANTIHYPERTENSIVE THERAPY; CIGARETTE SMOKING; CLINICAL TRIAL; COGNITIVE DEFECT; COMBINATION CHEMOTHERAPY; COMORBIDITY; DEMENTIA; DIETARY INTAKE; DRUG DOSE TITRATION; DRUG MEGADOSE; EDUCATION; EVIDENCE BASED MEDICINE; HEAD INJURY; HEART ATRIUM FIBRILLATION; HUMAN; HYPERHOMOCYSTEINEMIA; HYPERLIPIDEMIA; LIFESTYLE; MENTAL PERFORMANCE; MONOTHERAPY; MULTIINFARCT DEMENTIA; NON INSULIN DEPENDENT DIABETES MELLITUS; OCCUPATIONAL EXPOSURE; OCCUPATIONAL TOXICOLOGY; PHYSICAL ACTIVITY; PRIMARY PREVENTION; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; STROKE; SYSTOLIC HYPERTENSION; VITAMIN SUPPLEMENTATION;

EID: 35148901140     PISSN: 15525260     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jalz.2007.07.005     Document Type: Review

References (24)

1. Patterson C., Feightner J.W., Garcia A., and MacKnight C.R. General risk factors for dementia. a systematic evidence review. Alzheimers Dement (2007) 3
2. Black S.E., Patterson C., and Feightner J. Preventing dementia. Can J Neurol Sci 28 Suppl 1 (2001) S56-S66
3. Hsuing G.-Y.R., and Sadovnick A.D. Genetics and dementia. risk factors, diagnosis and management. Alzheimers Dement (2007) 3
4. Woolf S.H., Battista R.N., Anderson G.M., et al. Assessing the clinical effectiveness of preventive manoeuvres: analytic principles and systematic methods in reviewing evidence and developing clinical practice recommendations. J Clin Epidemiol 43 (1990) 891-905
5. Hunt D.L., and McKibbon K.A. Locating and appraising systematic reviews. In: Mulrow C., and Cook D. (Eds). Systematic reviews: synthesis of best evidence for health care decisions (1998), American College of Physicians, Philadelphia 13-22
6. Shumaker S.A., Legault C., Kuller L., Rapp S.R., Thal L., Lane D.S., et al. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study. JAMA 291 (2004) 2947-2958
7. Forette F., Seux M.-L., Staessen J.A., Thijs L., Birkenhäger W.H., Babarskiene M.R., et al. Prevention of dementia in randomized double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet 352 (1998) 1347-1351
8. The PROGRESS Collaborative Group. Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. Arch Intern Med 163 (2003) 1069-1075
9. Feigin V., Ratnasabapathy Y., and Anderson C. Does blood pressure lowering treatment prevent dementia or cognitive decline in patients with cardiovascular and cerebrovascular disease?. J Neurol Sci 229-230 (2005) 151-155
10. McGuinness B., Todd S., Passmore P., and Bullock R. The effects of blood pressure lowering on development of cognitive impairment and dementia in patients without apparent prior cerebrovascular disease. Cochrane Database Syst Rev 2 (2006) CD004034
11. Areosa Sastre A., and Grimley Evans J. Effect of the treatment of Type II diabetes mellitus on the development of cognitive impairment and dementia. Cochrane Database Syst Rev 4 (2004) CD003408
12. Gorelick P.B., Sacco R.L., Smith D.B., et al. Prevention of a first stroke: a review of guidelines and a multidisciplinary consensus statement from the National Stroke Association. JAMA 281 (1999) 1112-1120
13. Scott H.D., and Laake K. Statins for the prevention of Alzheimer's disease. Cochrane Database Syst Rev 1 (2006) accession number: 00075320-100000000-02141
14. Shepherd J., Blauw G.J., Murphy M.B., Bollen E.L., Buckley B.M., Cobbe S.M., et al. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomized controlled trial. Lancet 360 (2002) 1623-1630
15. Hart R.G., Benavente O., McBride R., and Pearce L.A. Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis. Ann Intern Med 131 (1999) 492-501
16. Aguilar M.I., and Hart R. Oral anticoagulants for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks. Cochrane Database Syst Rev 1 (2006) accession number: 00075320-100000000-01342
17. Lim W., Gammack J., Van Niekerk J., and Dangour A. Omega 3 fatty acid for the prevention of dementia. Cochrane Database Syst Rev (2006) CD005379
18. MacLean C.H., Issa A.M., Newberry S.J., Mojica W.A., Morton S.C., Garland R.H., et al. Effects of omega-3 fatty acids on cognitive function with aging, dementia, and neurological diseases. Evidence Report/Technology Assessment 114 (2005) 13-16
19. Etminan M., Gill S., and Samii A. Effect of non-steroidal anti-inflammatory drugs on risk of Alzheimer's disease: systematic review and meta-analysis of observational studies. BMJ 327 (2003) 128
20. Szekely C.A., Thorne J.E., Zandi P.P., Ek M., Messias E., Breitner J.C., et al. Nonsteroidal anti-inflammatory drugs for the prevention of Alzheimer's disease: a systematic review. Neuroepidemiology 23 (2004) 159-169
21. de Craen A.J.M., Gussekloo J., Vrijsen B., and Westendorp R.G.J. Meta-analysis of nonsteroidal antiinflmmatory drug use and risk of dementia. Am J Epidemiol 161 (2005) 114-120
22. ADAPT Research Group. Naproxen and celecoxib do not prevent AD in early results from a randomized controlled trial. Neurology 68 (2007) 1800-1808
23. Zandi P.P., Anthony J.C., Khachaturian A.S., Stone S.V., Gustafson D., Tschanz J.T., et al. Reduced risk of Alzheimer disease in users of antioxidant vitamin supplements: the Cache County Study. Arch Neurol 61 (2004) 82-88
24. Boothby L.A., and Doering P.L. Vitamin C and vitamin E for Alzheimer's disease. Ann Pharmacother 39 (2005) 2073-2080